Health Economics, Health Policy and Healthcare Management

Ailawadhi has expertise in the field of plasma cell disorders, specifically multiple myeloma and focuses on clinical drug development as well as a special interest in secondary data analysis looking at outcome disparities and healthcare economics. He has accumulated vast experience in the area of disparities in healthcare utilization and outcomes by patient race and ethnicity and how the management, access and effects of therapeutic interventions may be different for various patient subgroups. Several of his research projects focusing on healthcare economics, cost-effectiveness and outcome disparities have been recognized in the form of presentations at national and international meetings as well as peer-reviewed publications.

Sinéad Furey graduated from Ulster University (Northern Ireland) with a research degree (DPhil), with specialties including food and consumer policy and legislation. She started working at the Consumer Council where she continued her research as a Senior Consumer Affairs Officer in food, water and consumer policy; as a Nutritional Associate at the Education and Training Inspectorate inspecting approaches to whole-school food policies and practices and as a senior Executive Officer at the Food Standards Agency where she led food policy research programmes. She currently lectures and researches at Ulster University with research interests in food poverty and food access.

Health Economics

Katarzyna Kolasa has more than 16 years of working experience in the healthcare sector, with 10 years with the pharmaceutical and medical devices industry and six with the public payer. In the past, she worked at both global and regional HEOR functions at AstraZeneca and BiogenIdec being based in Sweden and Switzerland respectively. At Bristol Myers Squibb and Lunbeck she was leading Market Access teams in CEE and Nordic Region. Her practical skills in the field of health economics were developed during six years employment contract at the Kalmar County Council in Sweden. Since 2015, she has been working with pricing &reimbursement challenges in the field of medical devices. Currently being Global Market Access Principal Consultant for Straub Medical. Before that, Katarzyna was a Senior HEOR Director at GE Healthcare.

Health Economics

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.